Corporate Donations

Waters - Mass spectrometer

Servier Canada - Endovascular scan

Waters

The Waters-CHUS partnership has been enhanced in an impressive manner with the donation of a Synapt mass spectrometer to the CHUS. This device represents the latest generation in mass spectrometry. With an Ultra Performance Liquid Chromatography System, fingerprinting and the study of metabolic profiles of biological fluids from patients with diseases, and a comparison to those of healthy subjects is made possible. It also permits the accurate mass measurement of various products. This donation has led to the founding of the Centre d’expertise en spectrométrie de masse clinique Waters-CHUS. Thus, the CHUS will continue to play a leading role in the field of genetic biochemistry.

Christiane Auray-Blais, LL.M., Ph.D., scientific director of Centre d’expertise en spectrométrie de masse clinique Waters-CHUS and the UPLC-QTOF Synapt, donation from Waters to the CHUS Foundation.

Servier Canada

The Centre hospitalier universitaire de Sherbrooke (CHUS) has purchased an endovascular scan, already in use by the cardiology department, thanks to a donation of $100 000 from the pharmaceutical company Servier Canada Inc. and a contribution from the CHUS Foundation. This ultrasound system ensures the continuity of care using cutting-edge technology that enables examinations complementing conventional diagnostic coronary angiography to be carried out.

From left to right: Jean-Michel Carpentier (Servier Canada Inc.), Dr Michel Nguyen (CHUS), Linda Cormier (CHUS),  Lynn Charpentier (president of the CHUS Foundation Board of Directors), Brad Lloyd (Servier Canada Inc. )  et Michel Fortin (director general of the CHUS Foundation).